Overview of Gemcitabine Activity in Advanced Breast Cancer
To access this article, please choose from the options below
Dr Smith has received honoraria from Eli Lilly and Company.
PII: S0093-7754(06)00141-2
doi:10.1053/j.seminoncol.2006.03.020
© 2006 Elsevier Inc. All rights reserved.
